Tomoyuki Tsumuraya

Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

Eisaku Kondo, Ken Saito, Yuichi Tashiro et al. · Nature Communications · 2012 · 156 citations · Full text

Pharmacy, Oncology, Pharmaceutics +14

Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia

Tomoyuki Tsumuraya, Chie Ishikawa, Yoshiaki Machijima et al. · Biochemical Pharmacology · 2011 · 83 citations

Medicine, Cancer Biology, Oncology +3

Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter

Moritoshi Higa, Chiaki Katagiri, Chigusa Shimizu‐Okabe et al. · Biochemical and Biophysical Research Communications · 2015 · 35 citations · Full text

Pharmacy, Oncology, Pharmaceutics +16

The crucial role of the TRPM7 kinase domain in the early stage of amelogenesis

Kayoko Ogata, Tomoyuki Tsumuraya, Kyoko Oka et al. · Scientific Reports · 2017 · 27 citations · Full text

Dentistry, Developmental Biology, Oral Biology +17

Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons

Gakuya Takamatsu, Chiaki Katagiri, Tomoyuki Tsumuraya et al. · Biochemical and Biophysical Research Communications · 2016 · 21 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17